← Browse by Condition
Medical Condition
leukemia myeloid
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2
NCT06501196 Phase 1
Recruiting
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Enrollment
170 pts
Location
United States
Sponsor
BlossomHill Therapeutics
NCT05805605 Phase 2
Recruiting
Allo HSCT Using RIC and PTCy for Hematological Diseases
Enrollment
56 pts
Location
United States
Sponsor
Masonic Cancer Center, Univers...
NCT05143840 Phase 2
Recruiting
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Enrollment
100 pts
Location
United States
Sponsor
Augusta University